Dare Bioscience Inc (DARE)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $12.93M
Last updated: Nov 17, 2026 at 11:03 AM ET
Dare Bioscience Inc (DARE) Competitors
The companies most similar to Dare Bioscience are Biocardia (BCDA), Ensysce Biosciences (ENSC) and Biovie (BIVI). By market cap, Dare Bioscience ranks 7th of the 13 companies on this page; Barinthus Biotherapeutics (BRNS) is the largest at $30.23M.
Peer Comparison
DARE's revenue growth of 499.6% is above the peer median of -0.3%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Dare Bioscience (DARE) | $12.93M | N/A | 6.4x | 0.0% | N/A | 499.6% | 0.00% |
| Biocardia Inc (BCDA) | $12.58M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Ensysce Biosciences Inc (ENSC) | $8.14M | N/A | 1.2x | -280.5% | -260.6% | -15.1% | 0.00% |
| Biovie Inc (BIVI) | $12.12M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Passage Bio Inc (PASG) | $13.68M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Dyadic International Inc (DYAI) | $13.10M | N/A | 4.4x | -200.5% | -224.8% | -0.6% | 0.00% |
| Psyence Biomedical Ltd. Common Shares (PBM) | $12.00M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Edesa Biotech Inc (EDSA) | $26.21M | N/A | N/A | 0.0% | N/A | -99.9% | 0.00% |
| Tvardi Therapeutics, Inc. (TVRD) | $15.74M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Barinthus Biotherapeutics plc (BRNS) | $30.23M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Seres Therapeutics Inc (MCRB) | $14.27M | N/A | 6.6x | 0.0% | N/A | 68.9% | 0.00% |
| VistaGen Therapeutics Inc (VTGN) | $8.01M | N/A | 3.4x | 0.0% | N/A | -46.5% | 0.00% |
| Chemomab Therapeutics Ltd DRC (CMMB) | $12.31M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $12.84M | N/A | 3.9x | 0.0% | -242.7% | -0.3% | 0.00% |
Similar Companies
These are the 12 companies most similar to Dare Bioscience, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Biocardia Inc (BCDA) | BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease. | BCDA competitors |
| Ensysce Biosciences Inc (ENSC) | Ensysce Biosciences, Inc., a clinical-stage biotechnology company, is dedicated to the development of various prescription drugs. | ENSC competitors |
| Biovie Inc (BIVI) | BioVie Inc., a clinical-stage biotechnology company, is dedicated to the discovery, development, and commercialization of drug therapies in the United States. | BIVI competitors |
| Passage Bio Inc (PASG) | Passage Bio, Inc., a genetic drug company, develops transformative therapies for rare monogenic central nervous system (CNS) diseases. | PASG competitors |
| Dyadic International Inc (DYAI) | Dyadic International, Inc., a biotechnology platform company, develops, produces and sells enzymes and other proteins in the United States. | DYAI competitors |
| Psyence Biomedical Ltd. Common Shares (PBM) | Psyence Biomedical Ltd. (PBM) is an innovative biotechnology company focused on harnessing the therapeutic potential of psychedelic compounds to address mental... | |
| Edesa Biotech Inc (EDSA) | Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development... | EDSA competitors |
| Tvardi Therapeutics, Inc. (TVRD) | Tvardi Therapeutics, Inc. is an innovative clinical-stage biopharmaceutical company focused on developing novel oncology therapies to meet critical unmet... | TVRD competitors |
| Barinthus Biotherapeutics plc (BRNS) | Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, engages in developing novel T cell immunotherapeutics to guide the immune system... | BRNS competitors |
| Seres Therapeutics Inc (MCRB) | Seres Therapeutics, Inc., a microbiome therapeutic platform company, is involved in the development of bacterial consortia that are designed to functionally... | MCRB competitors |
| VistaGen Therapeutics Inc (VTGN) | VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing and commercializing several drugs with the potential... | VTGN competitors |
| Chemomab Therapeutics Ltd DRC (CMMB) | Chemomab Therapeutics Ltd. is dedicated to the research and development of biological drugs for the treatment of inflammatory and fibrotic diseases. | CMMB competitors |
Frequently Asked Questions About DARE
Who are Dare Bioscience's main competitors?
The companies most similar to Dare Bioscience include Biocardia (BCDA), Ensysce Biosciences (ENSC), Biovie (BIVI), Passage Bio (PASG) and Dyadic International (DYAI), listed from the closest match.
Who is Dare Bioscience's biggest competitor?
Barinthus Biotherapeutics (BRNS) is the largest of the similar companies at $30.23M; Biocardia (BCDA) is the closest match by business profile, size, sector and industry.
How does DARE stock compare with its competitors?
DARE's P/S is 6.4x against a peer median of 3.9x; its net margin is 0.0% against a peer median of 0.0%.
Which of Dare Bioscience's competitors pays a higher dividend?
Dare Bioscience pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Dare Bioscience bigger than its competitors?
No. Dare Bioscience is 7th by market cap among the 13 companies on this page; the largest is Barinthus Biotherapeutics (BRNS) at $30.23M.
DARE pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors